Association of Pre-Treatment Nutritional Status with CD4 and Viral Load Response to Antiretroviral Therapy in Rwandan Women Context Results Summary  Body.

Slides:



Advertisements
Similar presentations
Antiretroviral therapy eligibility at enrollment and time to treatment initiation in Ethiopia Chloe A. Teasdale 1, Chunhui Wang 1, Sileshi Lulseged 1,
Advertisements

DACS 272 Neurologic deficits in the years following ART initiation among subjects in the AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized.
The association between blood pressure, body composition and birth weight of rural South African children: Ellisras longitudinal study Makinta MJ 1, Monyeki.
Prevalence of and Progression to Abnormal Non-Invasive Markers of Liver Disease (APRI and FIB-4) among US HIV-infected Youth Kapogiannis B, Leister E,
Virologic and immunologic response following antiretroviral therapy initiation among pregnant and postpartum women with acute HIV-1 infection: MOPDB0101.
Chicago Housing for Health Partnership: HIV Outcomes David Buchanan MD MS, Romina Kee MD MPH, Laura Sadowski MD MPH, Diana Garcia MPH North American Housing.
1 Lauren E. Finn, 2 Seth Sheffler-Collins, MPH, 2 Marcelo Fernandez-Viña, MPH, 2 Claire Newbern, PhD, 1 Dr. Alison Evans, ScD., 1 Drexel University School.
First-Line HIV Therapy and Treatment Strategies: A Summary of Key CROI 2008 Research First-Line HIV Therapy and Treatment Strategies The Body PRO Coverage.
Noreen Clark, PhD Molly Gong, MD Melissa Valerio, MPH Sijian Wang, BS Xihong Lin, PhD William Bria, MD Timothy Johnson, MD University of Michigan School.
Patients in routine HIV clinical care at-risk for potentially transmitting HIV in the “test and treat” era of HIV prevention Crane, HM, Mimiaga, M, Feldman,
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Highlights of MACS and WIHS Protocol and Cohorts Lisa Jacobson Stephen Gange May 25, 2005 Not for distribution or publication outside the Multicenter AIDS.
WE-ACTx Women’s Equity in Access to Care and Treatment.
1FHI 360 Nigeria. 2USAID Nigeria
Patient Empowerment Impacts Medication Adherence among HIV-Positive Patients in the Veteran’s Health Administration Tan Pham 1,2,3, Kristin Mattocks 1,2,
M ALNUTRITION. M ALNUTRITION AMONG IDU S : B ASIC FACTS Drug users are at increased risk of malnutrition regardless of whether or not they are infected.
Effectiveness of Micronutrient-rich Lipid Nutrient Supplements in Delaying Clinical Progression of HIV in Malawian Adults Heidi Sandige, MD.
Reproductive Health Needs of Men and Women Enrolled in HIV Care and Treatment Services Elaine Abrams August 12, 2008 Track 1.0 Meeting.
Assessing the Response to Hepatitis B Immunizations in HIV-Positive Adults: Results from the 550 Clinic cohort study Camila Calderon 1, Anupama Raghuram.
The Effect of Gender Based Violence (GBV) on Mortality: a longitudinal study of US women with & at risk for HIV Kathleen M. Weber Steve R. Cole, Jane Burke-Miller,
Background There is uncertainty regarding the frequency, predictors, and outcomes of IRIS events Prior studies on IRIS have been limited to convenience.
Washington D.C., USA, JULY Rulin C. Hechter 1 MD,PhD Jean Q. Wang 1 PhD Margo A. Sidell 1 ScD William J. Towner 2 MD 1 Dept.
Slides current until 2008 Nutrition assessment. Curriculum Module III-5 Slide 2 of 25 ACTIVITY Slides current until 2008 Identify the factors that influence.
Transition Program of HIV-infected adolescents to Adult HIV care in Buenos Aires, Argentina S. Arazi Caillaud 1, D. Mecikovsky 1, A.Bordato.
Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection DR. S.K CHATURVEDI DR. KANUPRIYA CHATURVEDI.
Management and Development for Health (MDH)
Prevalence of Treated & Untreated Depression in a Cohort of HIV+ Women: Impact on Antiretroviral Therapy Utilization & HIV Disease Outcomes Judith A. Cook,
#735 KA Lichtenstein 1, C Armon 2, K Buchacz 3, AC Moorman 3, KC Wood 2, JT Brooks 3, and the HOPS Investigators 1 University of Colorado Health Sciences.
Vani Gandhi, MD Attending Physician Center for Comprehensive Care Director of Integrative Medicine St. Luke’s-Roosevelt Hospital Center Evaluation of Vitamin.
Theresa Banda. VI Operational Research Advocacy Technical support VN Production and marketing RUF Introduction.
Neurocognitive Impairment in HIV-Infected Subjects on HAART: Prevalence and Associations Kevin Robertson *1, Kunling Wu 2, Thomas Parsons 1, Ron Ellis.
Is Highly Active Antiretroviral Therapy (HAART) in pregnancy protective against maternal mortality? Results from a large DREAM cohort in Malawi and Mozambique.
Matthew Fox Center for Global Health & Development Department of Epidemiology Boston University Health Economics and Epidemiology Research Office July.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Press Briefing: Office of the Vice Chancellor MUK 6 th September 2010 The Infectious Diseases Institute Care and Research Initiatives Dr Alex G Coutinho.
Prevalence and Predictors of Metabolic Syndrome among HIV-Positive and Negative Women in the Women’s Interagency HIV Study ME. Sobieszczyk 1, D. Hoover.
Results Compliance with Breast Cancer Screening Guidelines in the HIV Clinic: A Quality Improvement Tool E. Patrozou M.D., E. Christaki M.D., L. Hicks.
1 The impact of ongoing illicit drug use on virologic suppression in HIV-infected injection drug users receiving HAART Authors: Harout Tossonian, Jesse.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Potential Utility of Tipranavir in Current Clinical Practice Daniel R. Kuritzkes, MD Director of AIDS Research Brigham and Woman’s Hospital Division of.
TREND AND RISK FACTORS FOR OBESITY AMONG HIV POSITIVE NIGERIANS ON ANTIRETROVIRAL THERAPY. Ezechi Lilian O. BSc, MSc, MEd Department of Home Economics.
HCV Co-infection is Associated with a High Risk of Osteoporotic Fractures Among HIV Patients Roger Bedimo, MD; Henning Drechsler, MD; Song Zhang, PhD;
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
HIV Testing in Acute Care Settings Rich Rothman, MD, PhD, FACEP CDC, DHHS, OraSure Technologies, Abbott  Historical.
Aspects of HIV in Denmark Jane Agergaard, MD, PhD Department of Infectious Diseases Aarhus University Hospital Skejby Denmark.
This presentation is intended for educational use only, and does not in any way constitute medical consultation or advice related to any specific patient.
Conclusions Materials and Methods Background Objectives HIV-1 RNA is the most significant determinant of cervical HIV-1 shedding. Shedding has also been.
1/11/01 Pediatric trials for ARV experienced children Coleen K. Cunningham Epidemiology of treatment experience in pediatrics How does the smaller number.
Figure 2: Trends in currently prescribed antiretroviral therapy % prescribed HAART increased from 74% to 83% Trends in ART use, HIV viral load, and CD4.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Influence of the Timing of Antiretroviral Therapy.
Estimating the population impact of homelessness on HIV viral suppression among people who use drugs Brandon DL Marshall, 1 Beth Elson, 1 Sabina Dobrer,
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.
HAART Initiation Within 2 Weeks of Seroconversion Associated With Virologic and Immunologic Benefits Slideset on: Hecht FM, Wang L, Collier A, et al. A.
CD4 trajectory among HIV positive patients receiving HAART in a large East African HIV care centre Agnes N. Kiragga 1, Beverly Musick 2 Ronald Bosch, Ann.
Chronic PTSD and HIV in Rwanda Mary Fabri, PsyD 1 ; Jianhong Lu, MS 2 ; Agnes Binagwaho, MD 3 ; Kathryn Anastos, MD 4 ; Mardge Cohen, MD 5 ; Davis Kashaka,
Previous SVR With Interferon-Based Therapy for HCV Lowers Risk of Hepatotoxicity in HIV/HCV-Coinfected Individuals on Antiretroviral Therapy Slideset on:
Effects of Alcohol and Crack Cocaine Use on Virological and Immunological Disease Progression in a Cohort of U.S. Women with HIV/AIDS Judith A. Cook, Ph.D.
ACTG 5142: First-line Antiretroviral Therapy With Efavirenz Plus NRTIs Has Greater Antiretroviral Activity Than Lopinavir/Ritonavir Plus NRTIs Slideset.
- Higher SBP visit-to-visit variability (SBV) has been associated
Earlier treatment and lower mortality in infants Initiating ART at
Improvement in post traumatic stress & depressive symptoms in HIV-infected Rwandan women on antiretroviral therapy Mardge H. Cohen, Mary Fabri, Xiaotao.
Pediatrics HIV/AIDS and PMTCT research in Barbados: lessons learned for monitoring the epidemic and evaluating the interventions.   ALOK KUMAR, MD. Lecturer.
Comparison of the study findings: Male & female
MHEALTH to Improve Health: Effectiveness of a weekly text messaging intervention to improve ART adherence and HIV Viral Load: WelTel OAKTREE. M.C.M. Murray1,2,3,
Adetunji Adejumo, MD; Cynthia Lee MA; Sharon Mannheimer, MD
Dorina Onoya1, Tembeka Sineke1, Alana Brennan1,2, Matt Fox1,2
Management and Development for Health (MDH)
Khai Hoan Tram, Jane O’Halloran, Rachel Presti, Jeffrey Atkinson
Public Health Implications
Presentation transcript:

Association of Pre-Treatment Nutritional Status with CD4 and Viral Load Response to Antiretroviral Therapy in Rwandan Women Context Results Summary  Body mass index, fat free mass, total body fat, hemoglobin and serum albumin measured prior to ART initiation did not predict virologic or immunologic response, in multivariate models.  The only significant predictors of greater CD4 increases on ART were lower pre-ART CD4 count, and lower income  Changes in viral load were predicted only by pre-ART HIV-1 RNA Kathryn Anastos MD 1,2, Qiuhu Shi PhD 3, Dalian Lu PhD 3, John Rusine MD 4, Mardge Cohen MD 2,5, François Ndamage MD 2.6, Agnes Binagwaho MD 2,7, Jules Mugabo MD 2,6, Donald Kotler MD 8 1.Montefiore Medical Center and Albert Einstein College of Medicine, Bronx NY. 2. Rwanda Women’s Interassociuation Study and Assessment (RWISA) Kigali, Rwanda; 3.Data Solution LLC, Bronx NY; 4. National Reference Laboratory, Ministry of Health, Kigali, Rwanda;; 5. Ruth M.. Rothstein CORE Center for the Prevention, Care, and Research of Infectious Diseases, Cook County Bureau of Health Services and Departments of Medicine, Stroger (formerly Cook County) Hospital and Rush Medical College, Chicago, Ill; 6. Treatment and Research in AIDS Center, Ministry of Health, Government of Rwanda, Kigali, Rwanda; 7. National Commission Against AIDS, Government of Rwanda, Kigali, Rwanda; 8. St. Luke’s/Roosevelt Hospital and Columbia University College of Physicians and Surgeons Contact Dr. Kathy Anastos: The global scale-up of care and treatment for persons living with HIV has made antiretroviral therapy (ART) available in populations with higher prevalence of low nutritional status than in the populations in which efficacy and toxicity of antiretroviral agents were assessed in clinical trials. Rwanda’s HIV treatment program strives to provide care and ART as indicated to all HIV-infected Rwandans. The implications of malnutrition in HIV infection may differ in higher- and lower-income settings - Poverty, food insecurity, hunger, and lack of food safety due to uncertain sanitation are greater in lower-income countries. -Societal consequences of malnutrition include greater threats to the integrity of the labor force and local health care systems in developing countries.  There has been little study of nutrition and HIV in lower-income countries - The need to provide HAART to as many patients as possible, as quickly as possible, has confounded attempts to optimize therapy. - Most nutritional studies have involved pregnant women and/or children. - Limited studies have shown effects of food insecurity on treatment adherence (1) as well as associations between late stage disease, malnutrition, and poor outcome (2) The Rwandan Women’s Interassociation Study and Assessment (RWISA) is a prospective observational cohort study established by Women’s Equity in Access to Care and Treatment (WE-ACTx Rwanda). RWISA enrolled 936 women in May-November 2005,710 HIV+ and 236 HIV-negative. and is designed to assess the effectiveness and toxicity of ART and the influence of comorbidities in Rwandan women. A major aim of RWISA is to determine the factors affecting treatment response in this cohort, especially post-traumatic stress syndrome and depression. All RWISA participants were ART-naïve at study entry. The RWISA enrollment visit included structured interview (to capture demographics, medical and psychosocial history), brief physical exam, collection of blood and cervical specimens, and body impedance analysis. POPULATION: 710 ART naïve HIV+ Rwandan women, of whom 543 initiated ART MEASUREMENTS:  Height, Weight and BMI  Bioelectric Impedance Analysis: body cell mass, fat mass, fat-free mass  Waist and hip circumferences, waist-to-hip ratio (WHR)  CD4 count at six-month intervals  HIV-1 RNA before and after ART initiation (in 231 ART initiators) Conclusion Methods Specific Aim To assess the association of pre-treatment body composition, serum markers and immune status on CD4 increase and viral load decline after initiation of ART Table 1: BaselineDemographic and Clinical Characteristics Table 2: Change in CD4 count and HIV-1 RNA in HIV+ women Table 3: Univariate and Multivariate Predictors of CD4 Change from pre-ART to longest follow-up (N = 400) Table 4: Univariate and Multivariate Predictors of Change in HIV-1 RNA from pre-ART to longest follow-up (N = 229) Measures of pre-treatment nutritional status in ART-naïve Rwandan women did not predict immunologic or virologic responses. This suggests that poorer pretreatment nutritional status, at least within the ranges of moderate malnutrition, does not prevent an excellent response to ART References 1. Au JT et al. Access to adequate nutrition is a major potential obstacle to antiretroviral adherence among HIV-infected individuals in Rwanda. AIDS 2006;20: Niyongabo T et al. Nutritional status of adult inpatients in Bujumbura, Burundi (impact of HIV infection). Euro J. of Clin. Nutri.1999;53: Poster 667, CROI 2008 Dr. Kathy Anastos voice